Abstract
Purpose
To determine the prevalence of malignant and premalignant endometrial polyps and to investigate the association of malignancy with specific factors.
Methods
This is a retrospective study of women submitted to hysteroscopic resection of endometrial polyps between January 2005 and July 2013 at a university hospital in southern Brazil. Data regarding clinical characteristics and pathology findings were collected from patient charts.
Results
Of 359 patients, 87.2 % had benign polyps and 9.9 % had hyperplasia without atypia. Atypical hyperplasia was found in 2.6 % of the sample. Endometrial adenocarcinoma was found in one woman (0.3 %). A correlation was observed between malignant/premalignant polyps and patient age, menopausal status, and uterine bleeding. All patients with malignancies/premalignancies had abnormal uterine bleeding. Higher frequency of malignant polyps was observed in tamoxifen users, however, without statistical significance (p = 0.059 %). Malignancy was not correlated with arterial hypertension, diabetes mellitus, obesity, hormone therapy, endometrial thickness, and polyp diameter.
Conclusions
Malignant/premalignant findings had low prevalence and were absent in asymptomatic patients. From the data of this retrospective study, it is unclear whether routine polypectomy should be performed in asymptomatic patients. Further prospective studies including larger numbers of patients are required to guide treatment recommendations.
Similar content being viewed by others
References
Tjarks M, Van Voorhis BJ (2000) Treatment of endometrial polyps. Obstet Gynecol 96:886–889
Vanni R, Dal Cin P, Marras S, Moerman P, Andria M, Valdes E, Deprest J, Van den Berghe H (1993) Endometrial polyp: another benign tumor characterized by 12q13-q15 changes. Cancer Genet Cytogenet 68:32–33
Nogueira AA, Sant’Ana de Almeida EC, Poli Neto OB, Zambelli Ramalho LN, Rosa e Silva JC, Candido dos Reis FJ (2006) Immunohistochemical expression of p63 in endometrial polyps: evidence that a basal cell immunophenotype is maintained. Menopause 13:826–830
Sant’Ana de Almeida EC, Nogueira AA, Candido dos Reis FJ, Zambelli Ramalho LN, Zucoloto S (2004) Immunohistochemical expression of estrogen and progesterone receptors in endometrial polyps and adjacent endometrium in postmenopausal women. Maturitas 49:229–233
Makris N, Kalmantis K, Skartados N, Papadimitriou A, Mantzaris G, Antsaklis A (2007) Three-dimensional hysterosonography vs. hysteroscopy for the detection of intracavitary uterine abnormalities. Int J Gynaecol Obstet 97:6–9
Savelli L, De Iaco P, Santini D, Rosati F, Ghi T, Pignotti E, Bovicelli L (2003) Histopathologic features and risk factors for benignity, hyperplasia, and cancer in endometrial polyps. Am J Obstet Gynecol 188:927–931
Ben-Arie A, Goldchmit C, Laviv Y, Levy R, Caspi B, Huszar M, Dgani R, Hagay Z (2004) The malignant potential of endometrial polyps. Eur J Obstet Gynecol Reprod Biol 115:206–210
Lieng M, Qvigstad E, Sandvik L, Jorgensen H, Langebrekke A, Istre O (2007) Hysteroscopic resection of symptomatic and asymptomatic endometrial polyps. J Minim Invasive Gynecol 14:189–194
Papadia A, Gerbaldo D, Fulcheri E, Ragni N, Menoni S, Zanardi S, Brusaca B (2007) The risk of premalignant and malignant pathology in endometrial polyps: should every polyp be resected? Minerva Ginecol 59:117–124
Antunes A Jr, Costa-Paiva L, Arthuso M, Costa JV, Pinto-Neto AM (2007) Endometrial polyps in pre- and postmenopausal women: factors associated with malignancy. Maturitas 57:415–421
Lieng M, Istre O, Qvigstad E (2010) Treatment of endometrial polyps: a systematic review. Acta Obstet Gynecol Scand 89:992–1002
Wang JH, Zhao J, Lin J (2010) Opportunities and risk factors for premalignant and malignant transformation of endometrial polyps: management strategies. J Minim Invasive Gynecol 17:53–58
Ayida G, Kennedy S, Barlow D, Chamberlain P (1996) Contrast sonography for uterine cavity assessment: a comparison of conventional two-dimensional with three-dimensional transvaginal ultrasound; a pilot study. Fertil Steril 66:848–850
Uglietti A, Mazzei C, Deminico N, Somigliana E, Vercellini P, Fedele L (2014) Endometrial polyps detected at ultrasound and rate of malignancy. Arch Gynecol Obstet 289:839–843
Serhat E, Cogendez E, Selcuk S, Asoglu MR, Arioglu PF, Eren S (2014) Is there a relationship between endometrial polyps and obesity, diabetes mellitus, hypertension? Arch Gynecol Obstet 290:937–941
Shushan A, Revel A, Rojansky N (2004) How often are endometrial polyps malignant? Gynecol Obstet Invest 58:212–215
Anastasiadis PG, Koutlaki NG, Skaphida PG, Galazios GC, Tsikouras PN, Liberis VA (2000) Endometrial polyps: prevalence, detection, and malignant potential in women with abnormal uterine bleeding. Eur J Gynaecol Oncol 21:180–183
Ferrazzi E, Zupi E, Leone FP, Savelli L, Omodei U, Moscarini M, Barbieri M, Cammareri G, Capobianco G, Cicinelli E, Coccia ME, Donarini G, Fiore S, Litta P, Sideri M, Solima E, Spazzini D, Testa AC, Vignali M (2009) How often are endometrial polyps malignant in asymptomatic postmenopausal women? A multicenter study. Am J Obstet Gynecol 200(235):e231–e236
Famuyide AO, Breitkopf DM, Hopkins MR, Laughlin-Tommaso SK (2014) Asymptomatic thickened endometrium in postmenopausal women: malignancy risk. J Minim Invasive Gynecol 21:782–786
Machtinger R, Korach J, Padoa A, Fridman E, Zolti M, Segal J, Yefet Y, Goldenberg M, Ben-Baruch G (2005) Transvaginal ultrasound and diagnostic hysteroscopy as a predictor of endometrial polyps: risk factors for premalignancy and malignancy. Int J Gynecol Cancer 15:325–328
Wethington SL, Herzog TJ, Burke WM, Sun X, Lerner JP, Lewin SN, Wright JD (2011) Risk and predictors of malignancy in women with endometrial polyps. Ann Surg Oncol 18:3819–3823
Baiocchi G, Manci N, Pazzaglia M, Giannone L, Burnelli L, Giannone E, Fratini D, Di Renzo GC (2009) Malignancy in endometrial polyps: a 12-year experience. Am J Obstet Gynecol 201(462):e461–e464
Costa-Paiva L, Godoy CE Jr, Antunes A Jr, Caseiro JD, Arthuso M, Pinto-Neto AM (2011) Risk of malignancy in endometrial polyps in premenopausal and postmenopausal women according to clinicopathologic characteristics. Menopause 18:1278–1282
Fernandez-Parra J, Rodriguez Oliver A, Lopez Criado S, Parrilla Fernandez F, Montoya Ventoso F (2006) Hysteroscopic evaluation of endometrial polyps. Int J Gynaecol Obstet 95:144–148
Hu R, Hilakivi-Clarke L, Clarke R (2015) Molecular mechanisms of tamoxifen-associated endometrial cancer (review). Oncol Lett 9:1495–1501
Bland AE, Calingaert B, Secord AA, Lee PS, Valea FA, Berchuck A, Soper JT, Havrilesky L (2009) Relationship between tamoxifen use and high risk endometrial cancer histologic types. Gynecol Oncol 112:150–154
DeWaay DJ, Syrop CH, Nygaard IE, Davis WA, Van Voorhis BJ (2002) Natural history of uterine polyps and leiomyomata. Obstet Gynecol 100:3–7
Preutthipan S, Herabutya Y (2005) Hysteroscopic polypectomy in 240 premenopausal and postmenopausal women. Fertil Steril 83:705–709
Cravello L, Stolla V, Bretelle F, Roger V, Blanc B (2000) Hysteroscopic resection of endometrial polyps: a study of 195 cases. Eur J Obstet Gynecol Reprod Biol 93:131–134
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflicts of interest to disclose. The authors have had full control of all primary data and they agree to allow the journal to review their data if requested. The authors have no financial relationships relevant to this article to disclose.
Rights and permissions
About this article
Cite this article
de Azevedo, J.M., de Azevedo, L.M., Freitas, F. et al. Endometrial polyps: when to resect?. Arch Gynecol Obstet 293, 639–643 (2016). https://doi.org/10.1007/s00404-015-3854-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-015-3854-3